Skip to main content

Table 3 The relationship of the ratio of etelcalcetide per session to oral cinacalcet per day with clinical factors

From: Effect of switching from cinacalcet to etelcalcetide on secondary hyperparathyroidism in patients undergoing hemodialysis: an ESCORT trial

 

45 patients

90 patients

 

Exp (estimate)

p value

Exp (estimate)

p value

Age

1.02

0.919

1.08

0.642

Sex

1.01

0.199

1.01

0.071

Duration of dialysis

0.74

0.147

0.81

0.221

spKt/V

0.54

0.087

0.58

< 0.05

cCa

1.00

0.989

0.96

0.779

P

1.01

0.904

0.97

0.642

iPTH

1.00

0.909

1.00

0.674

  1. 45 patients with intact PTH levels within the management target at screening and at the end of the study and with constant vitamin D agent and calcium-based phosphate binder doses
Back to article page

Renal Replacement Therapy

ISSN: 2059-1381

Contact us